Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicol Sci ; 114(2): 346-55, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20071423

ABSTRACT

Several noncardiovascular drugs have the potential to induce Torsades de Pointes cardiac arrhythmias via blockade of the rapid component of the cardiac delayed rectifier K(+) current (I(Kr)), which is encoded by human ether-à-go-go-related gene (hERG). The aim of the present study was to characterize possible interactions between terfenadine, binding to a site located inside the central cavity, and the following substances with various binding sites: dofetilide, fluvoxamine, chlorobutanol, and a hERG-specific toxin isolated from scorpion venom (CnErg1). The whole-cell configuration of the patch-clamp technique was employed on hERG channels stably expressed in human embryonic kidney 293 cells. Terfenadine does not interact with dofetilide or fluvoxamine at hERG channels. Slight subadditive inhibitory effects on hERG peak tail currents were observed when terfenadine and CnErg1 were administered in combination. Terfenadine and chlorobutanol synergistically inhibit hERG peak tail currents and enhance each other's inhibitory effect in a concentration-dependent way. In conclusion, terfenadine interacts with CnErg1 and chlorobutanol, but not with dofetilide or fluvoxamine, at hERG channels. It is shown that interactions between chlorobutanol and a hERG channel blocker binding inside the central cavity (terfenadine) produce synergistic effects on hERG currents.


Subject(s)
Ether-A-Go-Go Potassium Channels/genetics , Histamine H1 Antagonists, Non-Sedating/pharmacology , Terfenadine/pharmacology , Binding Sites/drug effects , Cell Line , Chlorobutanol/pharmacology , Drug Combinations , Drug Synergism , ERG1 Potassium Channel , Ether-A-Go-Go Potassium Channels/metabolism , Fluvoxamine/pharmacology , Humans , Kidney/cytology , Kidney/embryology , Kidney/metabolism , Patch-Clamp Techniques , Phenethylamines/pharmacology , Scorpion Venoms/pharmacology , Sulfonamides/pharmacology
2.
Brain Res ; 1170: 39-47, 2007 Sep 19.
Article in English | MEDLINE | ID: mdl-17692833

ABSTRACT

The postnatal development of the binding of the GABA(A) receptor agonist [(3)H]gaboxadol in rat brain was investigated. Using brain tissue from rats obtained at postnatal days 1, 10, 25, and >25 (adult), the binding of [(3)H]gaboxadol and the benzodiazepine [(3)H]flunitrazepam to GABA(A) receptors was compared in homogenate binding assays and quantitative receptor autoradiography. Kinetic and equilibrium data obtained in homogenate binding studies revealed two different [(3)H]gaboxadol affinities. A kinetically derived K(D) of 3.7 nM in adult cerebellum, calculated from the association and dissociation rate constants k(on) (1.45 x 10(8) M(-1) min(-1)) and k(off) (0.54 min(-1)) was contrasted by an equilibrium K(D) of 38.6 nM, obtained by homologous competition experiments. Quantitative analysis of autoradiographic data revealed an increase in specific [(3)H]gaboxadol binding sites during brain development, which resembles the anatomical and temporal pattern of the postnatal expression of the extrasynaptic delta subunit of GABA(A) receptors. In conclusion, by the radioligand binding data obtained on native tissue, binding of gaboxadol to GABA(A) receptors located outside the synaptic junctions could be postulated.


Subject(s)
Aging/physiology , Brain Chemistry/physiology , Brain/drug effects , Brain/growth & development , Isoxazoles/metabolism , Isoxazoles/pharmacokinetics , Animals , Animals, Newborn , Autoradiography/methods , Binding, Competitive/drug effects , Binding, Competitive/physiology , Brain/metabolism , Flunitrazepam/metabolism , Flunitrazepam/pharmacokinetics , GABA Agonists/metabolism , GABA Agonists/pharmacokinetics , GABA Modulators/metabolism , GABA Modulators/pharmacokinetics , Kinetics , Radioligand Assay/methods , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/drug effects , Receptors, GABA-A/metabolism , Subcellular Fractions , gamma-Aminobutyric Acid/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...